News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
432,130 Results
Type
Article (23942)
Company Profile (47)
Press Release (408141)
Multimedia
Podcasts (4)
Webinars (10)
Section
Business (135168)
Career Advice (1460)
Deals (23162)
Drug Delivery (30)
Drug Development (46698)
Employer Resources (60)
FDA (10507)
Job Trends (10578)
News (221553)
Policy (21631)
Tag
2027 Pharm Country Standard (1)
Academia (1804)
Accelerated approval (12)
Adcomms (7)
Allergies (43)
Alliances (29821)
ALS (58)
Alzheimer's disease (561)
Antibody-drug conjugate (ADC) (94)
Approvals (10674)
Artificial intelligence (90)
Autoimmune disease (45)
Automation (1)
Bankruptcy (205)
Best Places to Work (8204)
BIOSECURE Act (2)
Biosimilars (73)
Biotechnology (30)
Bladder cancer (38)
Brain cancer (19)
Breast cancer (206)
Cancer (1381)
Cardiovascular disease (140)
Career advice (1132)
Career pathing (4)
CAR-T (82)
CDC (5)
Cell therapy (186)
Cervical cancer (13)
Clinical research (39914)
Collaboration (367)
Company closure (3)
Compensation (233)
Complete response letters (13)
COVID-19 (679)
CRISPR (26)
C-suite (246)
Cystic fibrosis (41)
Data (1777)
Depression (44)
Diabetes (123)
Diagnostics (3968)
Digital health (10)
Diversity (1)
Diversity, equity & inclusion (16)
Drug discovery (47)
Drug pricing (32)
Drug shortages (6)
Duchenne muscular dystrophy (61)
Earnings (59329)
Editorial (15)
Employer branding (9)
Employer resources (51)
Events (66395)
Executive appointments (283)
FDA (11484)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (5)
Funding (331)
Gene editing (49)
Generative AI (7)
Gene therapy (152)
GLP-1 (387)
Government (2949)
Grass and pollen (5)
Guidances (164)
Healthcare (12255)
HIV (11)
Huntington's disease (6)
IgA nephropathy (28)
Immunology and inflammation (66)
Immuno-oncology (15)
Indications (42)
Infectious disease (754)
Inflammatory bowel disease (55)
Inflation Reduction Act (4)
Influenza (25)
Intellectual property (43)
Interviews (249)
IPO (11548)
IRA (8)
Job creations (2525)
Job search strategy (1048)
JPM (15)
Kidney cancer (7)
Labor market (17)
Layoffs (276)
Leadership (3)
Legal (5531)
Liver cancer (42)
Longevity (3)
Lung cancer (222)
Lymphoma (125)
Machine learning (5)
Management (19)
Manufacturing (143)
MASH (37)
Medical device (9328)
Medtech (9344)
Mergers & acquisitions (11731)
Metabolic disorders (265)
Multiple sclerosis (38)
NASH (6)
Neurodegenerative disease (86)
Neuropsychiatric disorders (18)
Neuroscience (926)
NextGen: Class of 2026 (6436)
Non-profit (3586)
Now hiring (5)
Obesity (96)
Opinion (129)
Ovarian cancer (58)
Pain (50)
Pancreatic cancer (58)
Parkinson's disease (97)
Partnered (5)
Patents (103)
Patient recruitment (126)
Peanut (23)
People (36637)
Pharmaceutical (13)
Pharmacy benefit managers (8)
Phase 1 (11541)
Phase 2 (17084)
Phase 3 (14397)
Pipeline (1517)
Policy (57)
Postmarket research (1152)
Preclinical (4316)
Press Release (58)
Prostate cancer (71)
Psychedelics (15)
Radiopharmaceuticals (65)
Rare diseases (241)
Real estate (4035)
Recruiting (28)
Regulatory (14731)
Reports (10)
Research institute (1558)
Resumes & cover letters (276)
Rett syndrome (6)
RNA editing (4)
RSV (18)
Schizophrenia (56)
Series A (45)
Series B (36)
Sickle cell disease (33)
Special edition (11)
Spinal muscular atrophy (132)
Sponsored (16)
Startups (2128)
Stomach cancer (10)
Supply chain (14)
Tariffs (6)
The Weekly (3)
Vaccines (249)
Venture capital (37)
Weight loss (72)
Women's health (23)
Worklife (2)
Date
Today (19)
Last 7 days (130)
Last 30 days (460)
Last 365 days (7205)
2026 (668)
2025 (7453)
2024 (9327)
2023 (11832)
2022 (19382)
2021 (22710)
2020 (29895)
2019 (49627)
2018 (36552)
2017 (32767)
2016 (31943)
2015 (37242)
2014 (30607)
2013 (25880)
2012 (27038)
2011 (27538)
2010 (22247)
Location
Africa (522)
Alabama (11)
Alaska (3)
Arizona (94)
Arkansas (6)
Asia (28558)
Australia (4245)
California (2529)
Canada (813)
China (412)
Colorado (80)
Connecticut (121)
Delaware (108)
Europe (63505)
Florida (274)
Georgia (85)
Hawaii (1)
Idaho (34)
Illinois (292)
India (18)
Indiana (141)
Iowa (1)
Japan (196)
Kansas (60)
Kentucky (7)
Louisiana (11)
Maine (16)
Maryland (330)
Massachusetts (1758)
Michigan (48)
Minnesota (174)
Mississippi (4)
Missouri (25)
Montana (5)
Nebraska (3)
Nevada (46)
New Hampshire (24)
New Jersey (987)
New Mexico (4)
New York (650)
North Carolina (394)
North Dakota (2)
Northern California (1308)
Ohio (76)
Oklahoma (2)
Oregon (9)
Pennsylvania (487)
Puerto Rico (3)
Rhode Island (14)
South America (798)
South Carolina (2)
Southern California (896)
Tennessee (23)
Texas (266)
United States (9296)
Utah (76)
Vermont (1)
Virginia (41)
Washington D.C. (31)
Washington State (236)
West Virginia (1)
Wisconsin (21)
432,130 Results for "201".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Immix Biopharma Receives U.S. FDA Breakthrough Therapy Designation for NXC-201
January 29, 2026
·
6 min read
Press Releases
Affinia Therapeutics Announces FDA Acceptance of IND Application to Advance AFTX-201 to a Phase 1/2 Trial for the Treatment of BAG3-Associated Dilated Cardiomyopathy (DCM)
February 5, 2026
·
4 min read
Press Releases
Immix Biopharma Appoints Chief Commercial Officer to Drive NXC-201 Launch
November 13, 2025
·
6 min read
Press Releases
Corvus Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $201M
January 26, 2026
·
4 min read
Press Releases
AnnJi Showcases Clinical Breakthrough of AJ201 at WMS 2025
October 13, 2025
·
3 min read
Press Releases
Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point
December 18, 2025
·
4 min read
Press Releases
Creative Medical Technology Holdings Announces World Health Organization Approval of “olastrocel” as INN for Lead Allogeneic Cell Therapy CELZ-201
December 3, 2025
·
3 min read
Press Releases
Blue Lake Biotechnology to Resume Enrollment of RSV-negative Toddlers in Phase 1/2a Clinical Trial of BLB201
November 24, 2025
·
5 min read
Press Releases
Atsena Completes Dosing in Part B of the Phase I/II/III LIGHTHOUSE Trial Evaluating ATSN-201 to Treat X-linked Retinoschisis and Announces Plans for Initiation of Pivotal Part C Cohort
January 8, 2026
·
6 min read
Press Releases
Minovia Therapeutics Receives FDA Orphan Drug Designation for MNV-201 in Myelodysplastic Syndrome
October 16, 2025
·
13 min read
1 of 43,213
Next
